US 9617540
Compounds and methods for modulating gene expression
granted A61PA61P1/16A61P3/00
Quick answer
US patent 9617540 (Compounds and methods for modulating gene expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P1/16, A61P3/00, A61P3/04, A61P3/06